AbbVie
ABBV
#26
Rank
โ‚ฌ348.97 B
Marketcap
197,68ย โ‚ฌ
Share price
1.68%
Change (1 day)
20.44%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚ฌ121.58 Billion

According to AbbVie's latest financial reports the company's total liabilities are โ‚ฌ121.58 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ126.65 B12.63%
2023-12-31โ‚ฌ112.45 B-0.73%
2022-12-31โ‚ฌ113.28 B-2.13%
2021-12-31โ‚ฌ115.75 B3.57%
2020-12-31โ‚ฌ111.76 B28.69%
2019-12-31โ‚ฌ86.84 B46.54%
2018-12-31โ‚ฌ59.26 B8.25%
2017-12-31โ‚ฌ54.74 B-6.31%
2016-12-31โ‚ฌ58.43 B30.11%
2015-12-31โ‚ฌ44.91 B111.94%
2014-12-31โ‚ฌ21.18 B18.45%
2013-12-31โ‚ฌ17.88 B0.08%
2012-12-31โ‚ฌ17.87 B205.89%
2011-12-31โ‚ฌ5.84 B43.1%
2010-12-31โ‚ฌ4.08 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ115.21 B-5.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ70.30 B-42.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ59.44 B-51.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ79.29 B-34.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ36.66 B-69.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ10.45 B-91.40%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ53.68 B-55.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ58.26 B-52.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ1.04 B-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA